CSF2 and neoplasm: The driving force behind this differentiation is believed to be GM-CSF produced by tumor cells, which can mediate the remote initiation of the transdifferentiation of erythroid cells into a myeloid lineage; intratumoral GM-CSF can create an inflammatory environment that facilitates the maturation of EDMC.